Dundee Corp DNDPF

Taurx article

[Catscratch]

Taurx anouncing additional results on Thursday.  Should also get an update on regulatory approvals in the not too distant future.  See article below suggesting US$15B valuation with approvals.  

https://www.nst.com.my/business/corporate/2024/03/1021303/maybank-ib-advises-investors-look-genting-given-its-involvement

Don't hold your breath.   But with positive results/approvals,Taurx could be very significant for Dundee.

[pierrelebel]

There is a similar article in Business Today (March 5): LINK The same US$15B value is implied "Under a ‘blue sky’ scenario where HMTM is approved and TauRx is valued at USD15b with no discount ascribed to it" Nothing new as the same US$15B was suggested two years ago. "Risk-reward profile heavily in favour of reward TauRx has initiated regulatory engagement in the United Kingdom

[TheCount11]

If it does get full approval $15B is very reasonable if not cheap.  Huge unmet need.  Imagine pill format with limited side effects.  A decade ago Novartis was doing over a billion USD with Exelon.

[pierrelebel]

A while back (late 2022) Mr Goodman wrote "Dundee holds 1,015,008 shares in TauRx, representing a 3.2% interest in the company. Dundee Corporation determined that the fair value of its investment in TauRx at September 30, 2022, was $38.5 million" In that "pie in the sky" valuation of US$15 billion, DC's share (3.2%) would be US$480 million or Cdn$ 650 million equivalent to